<DOC>
	<DOCNO>NCT00216606</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness individualize dos ( 50 200 milligram ) topiramate tablet compare placebo prevention chronic migraine headache period 16 week .</brief_summary>
	<brief_title>The Effectiveness Safety Topiramate Prevention Chronic Migraine</brief_title>
	<detailed_description>Previous study show topiramate effective preventing chronic migraine headache . This study start 4-week baseline period treatment give , follow 12-week period patient 's dose adjust keep stable last 4 week 16-week double-blind phase . The individualized dose start 25 milligram topiramate per day increase 25 milligram per day weekly raise either target -- 100 milligram per day -- maximum dose well tolerate 200 milligram per day . Patients randomize receive topiramate remain optimized dose . The comparison phase study 16-week period change migraine day patient topiramate ( take least 50 milligram per day ) compare change migraine day patient placebo . Also study patient ' health-related quality life assess questionnaire fill specific visit well patient ' view safety tolerability topiramate . The study hypothesis number migraine day , period , attack baseline period last 4 week double-blind period reduce topiramate group placebo group . During 16-week comparison period , patient take mouth dose 50 milligram 200 milligram topiramate daily .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>History migraine &gt; = 1 year Headache type meet HIS ( International Headache Society ) criteria migraine History reflect `` chronic '' headachean average &gt; = 15 migraine day per month 3 month precede trial entry History chronic migraine &gt; =1 year &gt; =15 headache per month average duration 4 hour treat Patient otherwise neurologically physically healthy pretrial exam . Any type chronic headache ( besides migraine ) section 2 13 International Headache Society classification headache result directly result factor ( except medication overuse ) Onset migraine age 50 Use anticonvulsant drug month prior trial entry Use antidepressant unless dose use stable dose &gt; =3 month Use migraine prevention medicine 3 month prior trial entry unless drug use least 3 month use stable dose least month Use carbonic anhydrase inhibitor acetazolamide ( use treat high blood pressure , glaucoma seizure ) triamterene ( `` water pill '' swell high blood pressure ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Chronic migraine</keyword>
	<keyword>Migraine</keyword>
	<keyword>Headache</keyword>
	<keyword>Migraine headache</keyword>
	<keyword>Topiramate</keyword>
</DOC>